NUGEN MEDICAL DEVICES INC (NGMD.CA) Stock Price, Forecast & Analysis
Canada - TSX-V:NGMD - CA67054F1009 - Common Stock
NGMD.CA Key Statistics, Chart & Performance
The current stock price of NGMD.CA is 0.04 CAD. In the past month the price decreased by -20%. In the past year, price decreased by -55.56%.
About NGMD.CA
Company Profile
Nugen Medical Devices, Inc. engages in the development of needle-free devices to administer therapeutics subcutaneously. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-05-28. The firm is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. The company is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. The company is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The firm's InsuJet technology platform is based on jet-stream administration of liquid drugs. The firm manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.
Company Info
NUGEN MEDICAL DEVICES INC
18 King Street East, Suite 1400
TORONTO ONTARIO CA
Employees: 0
Phone: 18332852666
NUGEN MEDICAL DEVICES INC / NGMD.CA FAQ
What does NGMD do?
Nugen Medical Devices, Inc. engages in the development of needle-free devices to administer therapeutics subcutaneously. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-05-28. The firm is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. The company is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. The company is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The firm's InsuJet technology platform is based on jet-stream administration of liquid drugs. The firm manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.
What is the current price of NGMD stock?
The current stock price of NGMD.CA is 0.04 CAD.
What is the dividend status of NUGEN MEDICAL DEVICES INC?
NGMD.CA does not pay a dividend.
What is the ChartMill rating of NUGEN MEDICAL DEVICES INC stock?
NGMD.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
NGMD.CA Technical Analysis
NGMD.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NGMD.CA. NGMD.CA may be in some trouble as it scores bad on both profitability and health.
NGMD.CA Financial Highlights
Over the last trailing twelve months NGMD.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS increased by 61.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -24.9% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |